Close
Nordic 9Nordic 9

Ackermans & van Haaren (investor - Others)

Belgium avh.be
See something wrong or missing? Let us know
Offices:Antwerp

Ackermans & van Haaren (AvH) is a Belgium based investment holding active in Marine Engineering & Contracting, Private Banking, Real estate and Senior Care, Energy & Resources, and Growth Capital.

Average round investment:62.9M USD
Average number per year:1.0
Distribution: 2025 (1)2024 (1)2023 (1)
Portfolio companies: Belgium MRM HealthBelgium Confo TherapeuticsNetherlands Vico Therapeutics
Mostly invests in: Belgium Belgium (2) Health services (3)

3 tracked investments in:

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

Investors with similar profile to Ackermans & van Haaren

Name Criteria
United States Walden Catalyst Ventures
83%
  • Range for average deal size: 50M - 100M USD
  • Similar verticals: Health services, Biotech, Manufacturing
  • Similar business models: B2B
  • Common investees countries: Netherlands
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
United States Driehaus Capital Management
83%
  • Range for average deal size: 50M - 100M USD
  • Similar verticals: Health services, Pharma, Biotech
  • Similar business models: B2B
  • Common investees countries: Belgium
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
United States Norwest Venture Partners
83%
  • Range for average deal size: 50M - 100M USD
  • Similar verticals: Health services, Biotech, Manufacturing
  • Similar business models: B2B
  • Common investees countries: Netherlands
  • Average number of deals per year: 1.2
  • Active last 12 months: Yes
Belgium UCB Ventures
83%
  • Range for average deal size: 50M - 100M USD
  • Similar verticals: Health services, Pharma, Biotech, Manufacturing
  • Similar business models: B2B
  • Common investees countries: Belgium
  • Average number of deals per year: 1.2
  • Active last 12 months: Yes
United States venBio Partners
83%
  • Range for average deal size: 50M - 100M USD
  • Similar verticals: Health services, Pharma, Biotech
  • Similar business models: B2B
  • Common investees countries: Netherlands
  • Average number of deals per year: 1.3
  • Active last 12 months: Yes
Japan Mitsubishi Corp
83%
  • Range for average deal size: 50M - 100M USD
  • Similar verticals: Health services, Biotech, Manufacturing
  • Similar business models: B2B
  • Common investees countries: Netherlands
  • Average number of deals per year: 1.7
  • Active last 12 months: Yes
United States MRL Ventures
83%
  • Range for average deal size: 50M - 100M USD
  • Similar verticals: Health services, Pharma, Biotech
  • Similar business models: B2B
  • Common investees countries: Belgium, Netherlands
  • Average number of deals per year: 1.7
  • Active last 12 months: Yes
Netherlands Partners in Equity
83%
  • Range for average deal size: 50M - 100M USD
  • Similar verticals: Health services, Pharma, Manufacturing
  • Similar business models: B2B
  • Common investees countries: Netherlands
  • Average number of deals per year: 1.8
  • Active last 12 months: Yes
Ireland Fountain Healthcare Partners
83%
  • Range for average deal size: 50M - 100M USD
  • Similar verticals: Health services, Pharma, Biotech, Manufacturing
  • Similar business models: B2B
  • Common investees countries: Belgium
  • Average number of deals per year: 2.0
  • Active last 12 months: Yes
Switzerland BioMedPartners
82%
  • Range for average deal size: 50M - 100M USD
  • Similar verticals: Health services, Pharma, Biotech, Manufacturing
  • Similar business models: B2B
  • Common investees countries: Belgium, Netherlands
  • Average number of deals per year: 2.6
  • Active last 12 months: Yes
Top